CT导向置管加尿激酶灌注引流治疗脑内血肿108例  

CT-guided catherization plus urokinase perfusion and drainage for intracerebral hematoma

作　　者：皮党育 杨炳湖[2] 李雪松[2] 荆国杰[2] 

机构地区：[1]惠州市惠阳区第二人民医院外科,广东惠州516002 [2]惠州市中心人民医院神经外科,广东惠州516001

出　　处：《临床和实验医学杂志》2007年第2期40-41,共2页Journal of Clinical and Experimental Medicine

摘　　要：目的探讨CT导向置管抽吸加尿激酶灌注溶凝引流治疗脑内血肿的效果,提高穿刺置管的准确性,从而提高治愈率,减少并发症。方法分析并总结108例不同类型的脑内血肿患者采用CT导向置管抽吸加尿激酶灌注溶凝引流治疗的经验。结果本组108例患者术后动态复查CT有106例血肿吸收消失,2例血肿增大改为开颅手术,临床死亡2例。按格拉斯格预后评分(GOS)分级评级,恢复良好96例、好转8例、未愈2例,临床死亡2例。结论CT导向置管抽吸配合尿激酶灌入溶凝引流治疗脑内血肿,具有手术风险低、创伤小、出血少、操作简单、术后恢复快等优点,在颅内血肿的微创治疗方面有较好的临床应用价值,但要筛选适合的病例。Objective To investigate the efficacy of CT - guided catherization and aspirate plus urokinase perfusion antieoagulation and drainage for the treatment of intracerebral hematoma. Mathods Data of 108 patients with different types of intracerebral hematoma treated by CT - guided catherization and aspirate plus urokinase perfusion anticoagulation and drainage were analysed. Results Intracerebral hematomas were absorbed in 106 patients after operation, which was confirmed by dynamic CT examination. Hematoma enlarged in 2 patients and a craniotomy was performed. According to GOS standard, 96 patients healed, 8 patients improved, 2 patients did not improve and 2 patients died. Conclusion CT - guided catherization and aspirate plus urokinase perfusion anticoagulation and drainage for the treatment of intracerebral hematoma has following advantages： low risk, mimimal trauma and haemorrhage, simple manipulation and quick recovery postoperatively.

关 键 词：CT导向 置管引流 脑内血肿 

分 类 号：R651.1[医药卫生—外科学] R743[医药卫生—临床医学]